Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ariad Pharmaceuticals
Ariad Pharmaceuticals
Can Baxalta hold off Shire with its own bid for Ariad?
Fierce Pharma
Mon, 08/31/15 - 11:20 am
Baxalta
Shire
M&A
Ariad Pharmaceuticals
Baxalta Said in Talks to Buy Ariad to Boost Cancer Offerings
Bloomberg
Fri, 08/28/15 - 05:59 pm
Baxalta
Ariad Pharmaceuticals
M&A
oncology
Ariad sells off a share of Iclusig for a shot at $200M in R&D cash
Fierce Biotech
Wed, 07/29/15 - 10:04 pm
Ariad Pharmaceuticals
R&D
Iclusig
acute lymphoblastic leukemia
PDL Biopharma
These biotech names are ripe for mergers: Analysts
CNBC
Sun, 05/10/15 - 02:04 pm
Biomarin
Sanofi
Shire
Gilead Sciences
Vertex Pharmaceuticals
Ariad Pharmaceuticals
Why These 2 Biotechs May Be Bought Out Soon
24/7 Wall St
Thu, 04/30/15 - 11:09 am
Esperion Therapeutics
Ariad Pharmaceuticals
Ariad CEO Berger to step down in settlement deal with Sarissa
Yahoo/Reuters
Wed, 04/29/15 - 09:23 am
Ariad Pharmaceuticals
Harvey Berger
Sarissa
Five companies that may be looking to buy Ariad Pharmaceuticals
Bizjournals.com
Wed, 04/15/15 - 08:44 am
Ariad Pharmaceuticals
M&A
Roche
Celgene
AbbVie
Gilead Sciences
Pfizer
Activist fund Sarissa wants to oust Ariad CEO
Yahoo/CNBC
Sat, 02/14/15 - 09:52 am
Ariad Pharmaceuticals
Activists want Ariad's CEO out the door, report says
Fierce Biotech
Fri, 02/13/15 - 08:37 am
activists
Ariad Pharmaceuticals
Pharma CEOs
Harvey Berger
Ariad tops 3Q profit forecasts
Yahoo/AP
Wed, 11/5/14 - 07:59 am
Ariad Pharmaceuticals
earnings
Ariad Pharma's lung cancer drug gets breakthrough therapy status
Yahoo/AP
Thu, 10/2/14 - 08:04 am
Ariad Pharmaceuticals
AP26113
FDA
lung cancer
breakthrough therapies
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors
Yahoo/BusinessWire
Sun, 06/1/14 - 11:36 am
Ponatinib
Ariad Pharmaceuticals
gastrointestinal stromal tumors
GSK declines comment on ARIAD rumors, Independent reports
The Fly on the Wall
Wed, 05/28/14 - 10:03 am
GSK
Ariad Pharmaceuticals
M&A
Better Bad News Buy: Ariad Pharmaceuticals vs. Exelixis
Motley Fool
Sat, 05/24/14 - 09:50 am
Ariad Pharmaceuticals
Exelixis
Why the Earnings Streak Will Continue for Ariad Pharmaceuticals (ARIA)
Yahoo/Zacks.com
Mon, 05/19/14 - 09:25 am
earnings
Ariad Pharmaceuticals
Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?
Motley Fool
Thu, 04/3/14 - 09:41 am
M&A
Ariad Pharmaceuticals
Eli Lilly
Iclusig
Jazz Pharmaceuticals
GSK
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
AbbVie
Amgen
Gilead Sciences
Achillion
Alexion
Ariad Pharmaceuticals
Pharmacyclics
Seattle Genetics
The Next Big Biotech Mover: Ariad Pharma
TheStreet.com
Wed, 03/19/14 - 03:45 pm
Ariad Pharmaceuticals
Merck Abandons Once-Promising Experimental Cancer Drug to Ariad
Wall St Cheat Sheet
Tue, 02/25/14 - 06:15 pm
Merck
Ariad Pharmaceuticals
ridaforolimus
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
Seeking Alpha
Mon, 02/24/14 - 09:19 am
Ignyta
oncology
Clovis Oncology
Ariad Pharmaceuticals
Mirati Therapeutics
Tesaro
Puma Biotechnology
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »